Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
Condition: Juvenile Dermatomyositis Interventions: Drug: Baricitinib; Biological: pharmacokinetics study; Biological: dosage of cytokines; Biological: transcriptomic analysis; Behavioral: Parent version of the Child Health Questionnaire (CHQ); Behavioral: Childhood Health Assessment Questionnaire; Biological: Pregnancy test Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials